MedPath

Effect of supplementation in treatment of women with polycystic ovary syndrome of IVF candidate

Phase 2
Conditions
Polycystic ovary syndrome.
Polycystic ovary syndrome
E28.2
Registration Number
IRCT201701025623N100
Lead Sponsor
Vice chancellor for research, Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
40
Inclusion Criteria

Patients with PCOS of IVF candidate according to Rotterdam criteria.
Aged 18 to 40 years

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insulin resistance. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Calculation using HOMA formula.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath